Evolent Health Inc (EVH) Stock Forecast & Price Target
Evolent Health Inc · NYSE
$3.73-0.08 (-2.10%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Evolent Health Inc, 9 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $3.00 to $18.00 (about 6.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $7.60 sits 104% above the current $3.73. The rating mix has stayed broadly stable, with Buy-side ratings easing from 12 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.05 next quarter toward $0.37 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Moderate Buy
Strong Buy00%
Buy964%
Hold536%
Sell00%
Strong Sell00%
Based on 14 analysts giving stock ratings to Evolent Health Inc.
As of Jul, 9 of 14 firms rate EVH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EVH EPS & revenue forecast
EPS · NEXT QUARTER
$0.05
Range $0.00 – $0.09 · 11 analysts · +9% YoY
Next period, 11 analysts expect Evolent Health Inc to earn $0.05 a share (range $0.00 – $0.09), versus $0.05 a year earlier. Full-year consensus is $0.20, growing to $0.37 the year after.
REVENUE · NEXT QUARTER
$684.6M
Range $634.9M – $733.2M · 11 analysts · +43% YoY
Revenue is expected to reach $684.6M (range $634.9M – $733.2M), +42.8% year-over-year. Full-year consensus is $2.5B, rising to $2.9B next year.
Top analysts covering Evolent Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EVH.
#1
Constantine Davides
JMP Securities · Rank #225
Buy
$10.00+168.1% to target
Overall win rate
34%
+ Follow
#2
Ryan MacDonald
Needham · Rank #386
Buy
$15.00+302.1% to target
Overall win rate
17%
+ Follow
#3
Jailendra Singh
Truist Securities
Hold
$7.00+87.7% to target
Coverage
—
+ Follow
#4
David Larsen
BTIG
Buy
$8.00+114.5% to target
Coverage
—
+ Follow
#5
Daniel Grosslight
Citigroup
Hold
$6.75+81.0% to target
Coverage
—
+ Follow
EVH stock forecast FAQ
What is EVH's average 12-month price target?+
The 13 analysts with a live target average $7.60 for Evolent Health Inc over the next 12 months, ranging from a $18.00 high to a $3.00 low.
Is EVH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 14 analyst ratings, 9 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EVH?+
The Street-high target is $18.00 (Piper Sandler), and the Street-low is $3.00 (RBC Capital). The average of all 13 active targets is $7.60.
How many Wall Street analysts cover EVH?+
14 analysts have an active rating on Evolent Health Inc, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering EVH?+
Among analysts who currently cover EVH, Constantine Davides of JMP Securities has the strongest overall Quantellect track record (Rank #225). Their current call is Buy with a $10.00 target.
What is Evolent Health Inc's projected EPS for next quarter?+
The consensus estimate is $0.05 per share (range $0.00 – $0.09) across 11 analysts. Full-year EPS is projected at $0.20, rising to $0.37 the following year.
How much revenue is Evolent Health Inc expected to report next quarter?+
Consensus revenue is $684.6M (range $634.9M – $733.2M). Full-year revenue is projected at $2.5B, growing to $2.9B next year.
Have analysts been upgrading or downgrading EVH lately?+
As of Jul, 9 of 14 firms rate EVH a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EVH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
